LDR Receives FDA Approval for the Mobi-C Cervical Disc for One-Level Use

By

LDR Receives FDA Approval for the Mobi-C Cervical Disc for One-Level Use (press release)

LDR, a privately held medical device company offering exclusive spinal implant technologies for both non-fusion and fusion applications, today announced that it has received a letter of approval from the U.S. Food and Drug Administration (FDA) allowing the commercial sale and distribution of the Mobi-C® Cervical Disc (Mobi-C), for one-level indications in the United States.
“I am very pleased now that Mobi-C is approved for one-level indications, as I will have the opportunity to offer my patients a stat...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.